Belgravia Hartford Cap Inc. (BLGVF)

[PotterBanker]

Belgravia Dermatology Completes Identification of Initial Drug Targets Within the Skin Endocannabinoid System and Also Identifies Bio Markers for Pre Clinical Work in Acne

https://globenewswire.com/news-release/2018/06/18/1525693/0/en/Belgravia-Dermatology-Completes-Identification-of-Initial-Drug-Targets-Within-the-Skin-Endocannabinoid-System-and-Also-Identifies-Bio-Markers-for-Pre-Clinical-Work-in-Acne.html

TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) today announced that its subsidiary, Belgravia Dermatology Inc. (“Belgravia Dermatology”) has completed the selection of initial drug targets and biological markers for its pre-clinical work in cannabinoid based dermatological treatments for unmet medical needs. The Company’s indications of interest include acne, atopic dermatitis, and psoriasis. The initial focus of product development is acne.